Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette–Guérin therapy in patients with non-muscle invasive bladder cancer
We demonstrated that numerous types of serum metabolites were altered in response to intravesical BCG and developed high-performance score models which might effectively differentiated the risk of post-BCG tumour recurrence.
Authors
- Yosuke Morizawa (ORCID: https://orcid.org/0000-0001-7142-5901)
- Takuya Owari (ORCID: https://orcid.org/0000-0002-9430-7518)
- Kiyohide Fujimoto (ORCID: https://orcid.org/0000-0003-1507-2464)
- Tatsuki Miyamoto
- Yuki Oda
- Sayuri Ohnishi
- Kenta Ohnishi
- Tomomi Fujii (ORCID: https://orcid.org/0000-0002-7207-4127)
- Makito Miyake (ORCID: https://orcid.org/0000-0001-9503-7356)
- Shunta Hori (ORCID: https://orcid.org/0000-0001-9514-9964)
- Daisuke Gotoh (ORCID: https://orcid.org/0000-0002-6056-3820)
- Takuto Shimizu (ORCID: https://orcid.org/0000-0002-6403-7959)
- Nobumichi Tanaka (ORCID: https://orcid.org/0000-0001-9242-7877)
- Nobutaka Nishimura
- Kota Iida
- Yasushi Nakai
Institutions
- Nara Medical University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Bladder Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/23523735251325100
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science